Clinical Trials Browser

Interventional × alovudine × Other solid neoplasm × Clear all

NCT02146222 2019-11-18

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific